Jeffrey Zekauskas Recent News
The Simple Case For Being A Chemours Bull
News For The Weed-Kend: An Update On Marijuana Business And Policy
After A Downgrade In June, Dow Chemical Back To Overweight For JPMorgan
JPMorgan: Monsanto Shares Could Hit $180 Over The Next 5 Years
JPMorgan Cuts Avery Dennison To Neutral
Calls Of Note: Shake Shack, Kate Spade And Other Notable Research Notes Worth Following On Tuesday
UPDATE: Monsanto Gains After Upgrade from J.P. Morgan
UPDATE: J.P. Morgan Reiterates On Valspar On F2014 EBITDA And Earnings Estimates